English
Home > Products > Miglitol API

China Miglitol API Factory

We've been experienced manufacturer. Wining the majority on the crucial certifications of its market for Miglitol API,CAS NO:72432-03-2,Miglitol, Top quality and competitive rates make our products and solutions appreciate a higher name all around the word.
Miglitol API, With excellent merchandise, high quality service and sincere attitude of service, we ensure customer satisfaction and help customers create value for mutual benefit and create a win-win situation. Welcome customers all over the world to contact us or visit our company. We are going to satisfy you with our expert service!

Related Products

Hot Products

  • 2,3-Dihydrobenzofuran

    2,3-Dihydrobenzofuran

    Product Name:2,3-Dihydrobenzofuran
    Molecular Formula:C8H8O
    Molecular Weight:120.15
    CAS Registry Number:496-16-2
  • 1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose

    1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose

    Product Name:1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose
    Molecular Formula:C21H21ClO5
    Molecular Weight:388.84
    CAS Registry Number:3601-89-6
  • Linagliptin

    Linagliptin

    Product Name:Linagliptin
    Molecular Formula:C25H28N8O2
    Molecular Weight;472.54
    CAS Registry Number;668270-12-0
  • Betrixaban

    Betrixaban

    Product Name:Betrixaban
    Molecular Formula:C23H22ClN5O3
    Molecular Weight;451.91
    CAS Registry Number;330942-05-7
  • Tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate

    Tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate

    Product Name:Tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate
    Molecular Formula:C14H22N4O2
    Molecular Weight:278.35
    CAS Registry Number:571188-59-5
  • 4-Morpholinopiperidine

    4-Morpholinopiperidine

    Product Name:4-Morpholinopiperidine
    Molecular Formula:C9H18N2O
    Molecular Weight:170.25
    CAS Registry Number:53617-35-9
  • Related Blog
  • Reviews

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept